| Literature DB >> 28292302 |
Frédéric Maes1,2, Sophie Pierard1,2, Christophe de Meester1,2, Jamila Boulif1,2, Mihaela Amzulescu1,2, David Vancraeynest1,2, Anne-Catherine Pouleur1,2, Agnès Pasquet1,2, Bernhard Gerber1,2, Jean-Louis Vanoverschelde3,4.
Abstract
BACKGROUND: The pathophysiology of paradoxical low-gradient (LG) severe aortic stenosis (SAS) remains controversial. As low transvalvular flow has been implicated, we sought to investigate the impact of left ventricular outflow tract (LVOT) ellipticity on the estimation of the LV stroke volume, the calculation of the aortic valve area (AVA) by use of the continuity equation and on AS severity grading.Entities:
Keywords: Aortic stenosis; Gradient; Left ventricular outflow tract
Mesh:
Year: 2017 PMID: 28292302 PMCID: PMC5351048 DOI: 10.1186/s12968-017-0344-8
Source DB: PubMed Journal: J Cardiovasc Magn Reson ISSN: 1097-6647 Impact factor: 5.364
Fig. 1Reprentatives examples of 2 orthogonal long-axis (panels a and b) and the resulting short-axis (panels c and d) images of the LVOT by CMR illustrating its elliptical shape
Baseline clinical and hemodynamic characteristics in the different subgroups
| Severe | Severe | Severe Paradoxical |
| |
|---|---|---|---|---|
| Age, yrs | 73 ± 12 | 74 ± 14 | 74 ± 14 | 0.44 |
| Male gender, | 77 (64%) | 21 (47%)* | 10 (40%)* | 0.02 |
| Body surface area, kg/m2 | 1.86 ± 0,19 | 1.81 ± 0,21 | 1.83 ± 0,20 | 0.83 |
| Arterial hypertension, | 84 (70%) | 38 (84%)* | 21 (88%)* | 0.046 |
| Diabetes, | 20 (17%) | 12 (27%) | 6 (24%) | 0.29 |
| Hyperlipidemia, | 86 (72%) | 27 (60%) | 24 (96%)*,† | 0.01 |
| Prior myocardial infarction, | 5 (4%) | 7 (16%)* | 3 (13%) | 0.04 |
| Prior coronary revascularization, | 15 (13%) | 5 (11%) | 5 (20%) | 0.49 |
| Atrial fibrillation, | 2 (2%) | 1 (2%) | 5 (20%)*,† | <0.01 |
* p < 0.05 vs HG-SAS; † p < 0.05 vs NF-PLG-SAS
Baseline hemodynamic, echocardiographic and CMR characteristics in the different subgroups
| Severe | Severe | Severe |
| |
|---|---|---|---|---|
|
| ||||
| Heart rate, bpm | 68 ± 10 | 69 ± 14 | 76 ± 16 | 0.17 |
| Systolic blood pressure, mmHg | 133 ± 17 | 141 ± 22* | 139 ± 21 | 0.70 |
| Diastolic blood pressure, mmHg | 74 ± 11 | 76 ± 11 | 75 ± 12 | 0.88 |
|
| ||||
| Indexed LV EDV, mL/m2 | 81 ± 18 | 73 ± 18* | 67 ± 14*,† | <0.01 |
| Indexed LV ESV, mL/m2 | 28 ± 10 | 26 ± 12 | 25 ± 8 | 0.14 |
| Indexed SV, mL/m2 | 54 ± 10 | 49 ± 9 | 43 ± 10 | <0.01 |
| LV ejection fraction, % | 59 ± 5 | 60 ± 6 | 57 ± 5 | 0.74 |
| CMR LVOT diameter, mm | 22 ± 2 | 21 ± 2 | 21 ± 2* | 0.20 |
| CMR LVOT area, cm2 | 5.0 ± 1.0 | 4.6 ± 0.9* | 4.6 ± 0.7 | 0.04 |
| CMR LVOT ellipticity index | 1.28 ± 0.08 | 1.28 ± 0.07 | 1.30 ± 0.10 | 0.64 |
|
| ||||
| 2D-LVOT diameter, mm | 22 ± 2 | 22 ± 2 | 20 ± 1*,† | 0.02 |
| 2D-echo LVOT area, cm2 | 3.8 ± 0.8 | 3.7 ± 0.6 | 3.3 ± 0.5* | 0.02 |
| 3D-echo LVOT area, cm2 | 5.3 ± 1.0 | 4.9 ± 0.9 | 4.6 ± 0.9 | 0.36 |
| LVOT VTI, cm/s | 22 ± 4 | 22 ± 3 | 16 ± 3*,† | <0.01 |
| 2D-indexed SV, mL/m2 | 44 ± 9 | 42 ± 5 | 29 ± 4*,† | <0.01 |
| Peak transaortic flow velocity, cm/s | 472 ± 49 | 366 ± 36* | 344 ± 42*,† | <0.01 |
| Mean pressure gradient, mm Hg | 56 ± 12 | 32 ± 6* | 29 ± 7*,† | <0.01 |
| 2D-indexed AVA, cm2/m2 | 0.38 ± 0.08 | 0.49 ± 0.06* | 0.39 ± 0.08† | <0.01 |
|
| ||||
| Fused indexed SV, mL/m2 | 57 ± 10 | 54 ± 8* | 41 ± 5*,† | <0.01 |
| Fused indexed AVA, cm2/m2 | 0.49 ± 0.09 | 0.62 ± 0.10* | 0.54 ± 0.11*,† | <0.01 |
Abbreviations: AVA aortic valve area, ERO effective orifice area, EDV end-diastolic volume, ESV end-systolic volume, LV left ventricular
* p < 0.05 vs HG-SAS; † p < 0.05 vs NF-PLG-SAS
Fig. 2Bland-Altman plots comparing 2D-echo and CMR measurements of the left ventricular outflow tract (LVOT) anterior-posterior diameters and cross-sectional area. On average, 2D-echo underestimated the LVOT area by 29% compared with CMR
Fig. 3Bland-Atman plots comparing 2D-echo and CMR measurements of indexed stroke volume (panel a) and of indexed AVA (panel b). On average, 2D-echo underestimated the indexed stroke volume and AVA by 29% compared with CMR
Fig. 4Bland-Atman plots comparing fused and CMR measurements of indexed stroke volume (panel a) and of indexed AVA (panel b). On average, inputting the planimetered LVOT area into the calculation of the indexed stroke volume by 2D-echo, corrected the underestimation of the indexed stroke volume and AVA by 2D-echo as compared to CMR
Fig. 5Indexed AVA (panel a) and fused indexed AVA (panel b) vs. mean gradient among 120 with HG-SAS and 70 patients with paradoxical LG-SAS. The predicted values from the fitted curve of the study population are presented